The NGF-driven upregulation of smad7, an inhibitory component of TGFβ1 pathway, and VEGF/cyr61 deserve further investigation, as opening to alternative approaches in counteracting fibrosis, especially for fibrotic eye diseases. Here, TGFB1 is linked to eye disorder.